OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Selinexor
15 minutes
Posted Jul 18, 2019 at 1:06 pm.
0:00
15:04
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
A brief discussion on FDA's approval decision on selinexor and its possible role in therapy. Then, a more in-depth details on its MOA, dosing, and toxicity profile.
Previous
Pain Management In Cancer
Next
AC - - > T (q week)
← See all 273 episodes of OncoPharm